Fecal Calprotectin in Dermatology Practice | PracticeUpdate

https://www.practiceupdate.com/c/102862/2/4/?elsca1=emc_enews_daily-digest&elsca2=email&elsca3=practiceupdate_derma&elsca4=dermatology&elsca5=newsletter&rid=NjA4ODYxMjU4ODkS1&lid=10332481

Fecal Calprotectin in Dermatology Practice

• Fecal calprotectin (FCP) levels have been shown to be elevated in patients with inflammatory bowel disease (IBD). Dermatologic manifestations associated with IBD may precede gastrointestinal symptoms.

• Although an elevated FCP level is predictive of an active bowel disease, a negative result does not necessarily rule out the disease when clinical suspicion is high. Further studies are needed to determine the utility of dermatologists ordering FCP in patients suspected of having cutaneous manifestations of IBD.

– Caitlyn T. Reed, MD

abstract

This abstract is available on the publisher's site.

Access this abstract now

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.